{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:34Z","timestamp":1787026354442,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is one of the most common gynecological endocrine disorders. Apelin and chemerin are newly identified adipokines, which are higher in obesity and diabetes. Studies have found that the serum apelin and chemerin levels in patients with PCOS are significantly increased. However, other studies showed the opposite results. Therefore, the relationship between those two adipokines and PCOS is still controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This meta-analysis was conducted to statistically evaluate the apelin and chemerin levels of patients with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the Web of Science, Embase, PubMed, and Google Scholar databases for potential studies. \u201cPolycystic ovary syndrome\u201d or \u201cPCOS\u201d in combination with the terms \u201capelin\u201d or \u201cchemerin\u201d were used as keywords search titles or abstracts. The publication period examined was between 1990 and 2021. Standardized mean differences (SMD) with corresponding 95% confidence intervals (CIs) were determined as the results of the meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 148 articles were initially retrieved, and 18 qualified articles were finally obtained through preliminary screening and quality evaluation. The publications together contain 1,265 cases and 894 controls. The results of the meta-analysis showed that the circulating chemerin levels in patients with PCOS were significantly higher than those in the controls (SMD: 0.79, 95% CI [0.36, 1.23]), and there was no significant difference in circulating apelin between patients with PCOS and controls (SMD: 0.57, 95% CI [-0.21, 1.35]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This meta-analysis is the first to evaluate circulating apelin and chemerin levels in patients with PCOS. Our findings suggest that circulating chemerin levels of patients with PCOS are significantly higher than those of healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=218316<\/jats:uri>\n                      , identifier CRD42020218316.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.1076951","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:22:34Z","timestamp":1673396554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yiming","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5803","article-title":"Polycystic ovary syndrome (PCOS) arguably the most common endocrinopathy is associated with significant morbidity in women","volume":"84","author":"Carmina","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0372-x","article-title":"Hyperinsulinism and polycystic ovary syndrome (PCOS) role of insulin clearance","volume":"38","author":"Amato","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.05.012","article-title":"Review apelin in disease","volume":"483","author":"Antushevich","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-011-9507-9","article-title":"Apelin, diabetes, and obesity","volume":"40","author":"Castan-Laurell","year":"2011","journal-title":"Endocrine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.diabres.2018.12.012","article-title":"Elevated blood apelin levels in type 2 diabetes mellitus a systematic review and meta-analysis","volume":"148","author":"Noori-Zadeh","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.013177","article-title":"International union of basic and clinical pharmacology CIII chemerin receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology, and function","volume":"70","author":"Kennedy","year":"2018","journal-title":"Pharmacol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0174","article-title":"Chemerin a multifaceted adipokine involved in metabolic disorders","volume":"238","author":"Helfer","year":"2018","journal-title":"J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113915","article-title":"Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2019-0500","article-title":"Circulating chemerin level and risk of cancer a systematic review and meta-analysis","volume":"14","author":"Qi","year":"2020","journal-title":"biomark Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1684\/ecn.2011.0279","article-title":"Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome","volume":"22","author":"Cekmez","year":"2011","journal-title":"Eur Cytokine Netw"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5152\/jtgga.2011.74","article-title":"Plasma apelin levels in patients with polycystic ovary syndrome","volume":"13","author":"Goren","year":"2012","journal-title":"J Turkish-German Gynecol Assoc"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.928687","article-title":"Elevated serum chemerin in Chinese women with hyperandrogenic PCOS","volume":"30","author":"Wang","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"B15","article-title":"Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome","volume":"66","author":"Ademoglu","year":"2014","journal-title":"Minerva Ginecol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"118310","DOI":"10.1016\/j.lfs.2020.118310","article-title":"Apelin\/Apelin receptor a new therapeutic target in polycystic ovary syndrome","volume":"260","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","article-title":"New markers of insulin resistance in polycystic ovary syndrome","volume":"40","author":"Polak","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.04.044","article-title":"Lower serum apelin levels in women with polycystic ovary syndrome","volume":"95","author":"Chang","year":"2011","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0300060516645421","article-title":"Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome","volume":"44","author":"Guvenc","year":"2016","journal-title":"J Int Med Res"},{"key":"B20","unstructured":"WellsGA\n            SheaB\n            O\u2019ConnellD\n            PetersonJ\n            WelchV\n            LososM\n          The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses2014"},{"key":"B21","unstructured":"HigginsJPT\n            GreenS\n          Cochrane handbook for systematic reviews of interventions version 5.1.02014"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2012.08.005","article-title":"Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-\u03b1 levels in non-obese women with polycystic ovary syndrome","volume":"77","author":"Choi","year":"2012","journal-title":"Steroids"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2014.02.022","article-title":"Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome","volume":"176","author":"Altinkaya","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"536896","DOI":"10.1155\/2014\/536896","article-title":"Does polycystic ovary syndrome itself have additional effect on apelin levels","volume":"2014","author":"Benk","year":"2014","journal-title":"Obstet Gynecol Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.888412","article-title":"Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome","volume":"30","author":"Guzel","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.09.015","article-title":"Increased serum chemerin concentrations in patients with polycystic ovary syndrome relationship between insulin resistance and ovarian volume","volume":"450","author":"Huang","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/cen.12687","article-title":"Circulating anti-mullerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome","volume":"83","author":"Olszanecka-Glinianowicz","year":"2015","journal-title":"Clin Endocrinol (OXF)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1124260","article-title":"Is there association between vitamin d levels, apelin 36, and visfatin in PCOS","volume":"32","author":"Kiyak Caglayan","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/09513590.2015.1075501","article-title":"Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women","volume":"32","author":"Yang","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2019.1695248","article-title":"Relationship between adipocytokines and angiotensin converting enzyme gene insertion\/deletion polymorphism in lean women with and without polycystic ovary syndrome","volume":"36","author":"O\u017cegowska","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/nu11112566","article-title":"Metabolic cytokines at fasting and during macronutrient challenges influence of obesity, female androgen excess and sex","volume":"11","author":"Martinez-Garcia","year":"2019","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.01.050","article-title":"Serum chemerin levels in polycystic ovary syndrome after metformin therapy","volume":"13","author":"Foda","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2020.1769061","article-title":"Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome","volume":"36","author":"Abruzzese","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1424","article-title":"Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome","volume":"153","author":"Wang","year":"2012","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"21328","DOI":"10.1038\/srep21328","article-title":"CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone","volume":"6","author":"Tang","year":"2016","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des089","article-title":"Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells","volume":"27","author":"Reverchon","year":"2012","journal-title":"Hum Reprod"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.894926","article-title":"Evaluation of apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus metformin","volume":"21","author":"Sun","year":"2015","journal-title":"Med Sci Monit"},{"key":"B38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0035-1552582","article-title":"The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome. semin","volume":"33","author":"Tal","year":"2015","journal-title":"Reprod Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/1933719118770547","article-title":"Adiponectin and chemerin contrary adipokines in regulating reproduction and metabolic disorders","volume":"25","author":"Anusha","year":"2018","journal-title":"Reprod Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2008-2231-22-39","article-title":"Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation","volume":"22","author":"Kabiri","year":"2014","journal-title":"DARU"},{"key":"B41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.anireprosci.2009.01.009","article-title":"Apelin and APJ receptor expression in granulosa and theca cells during different stages of follicular development in the bovine ovary involvement of apoptosis and hormonal regulation","volume":"116","author":"Shimizu","year":"2009","journal-title":"Anim Reprod Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.5.344","article-title":"The expression of apelin and its receptor APJ during different physiological stages in the bovine ovary","volume":"5","author":"Schilffarth","year":"2009","journal-title":"Int J Biol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1076951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:22:42Z","timestamp":1673396562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1076951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":42,"alternative-id":["10.3389\/fendo.2022.1076951"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1076951","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"article-number":"1076951"}}